Editing
CUA: Advanced and Metastatic Urothelial Cancer (2019)
(section)
Jump to navigation
Jump to search
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===== Background ===== * In Canada, bladder cancer ranks as the 5th most common cancer with an estimated 8900 new cases and 2400 deaths in 2018. * Approximately 15% of patients have locally advanced or metastatic disease at presentation. A further 40 β 50% of those with muscle invasive early stage disease will relapse after initial treatment * The majority of patients with advanced stage disease will succumb to their disease. * '''Cancers of the ureter, renal pelvis and proximal urethra''' constitute approximately 5-10% of cases of urothelial carcinoma and '''are treated with similar systemic therapy as bladder cancer.''' * '''In this consensus statement, locally advanced disease is defined as cT4b and / or cN1-3.'''
Summary:
Please note that all contributions to UrologySchool.com may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
UrologySchool.com:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Page
Discussion
English
Views
Read
Edit
Edit source
View history
More
Search
Navigation
Main page
Clinical Tools
Guidelines
Chapters
Landmark Studies
Videos
Contribute
For Patients & Families
MediaWiki
Recent changes
Random page
Help about MediaWiki
Tools
What links here
Related changes
Special pages
Page information